More on XNPT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.0 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- M&A (9/30/16 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

XNPT Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 22.88M
Short-term investments 97.3M
Prepaids and other current assets
Total current assets 135.83M
Property and equipment, net 1.68M
Restricted investments and other assets 0
Total assets 150.19M
Accounts payable 3.01M
Accrued compensation 5.12M
Accrued preclinical and clinical costs 1.32M
Other accrued liabilities
Deferred rent
Deferred revenue 1.13M
Total current liabilities 17.92M
Deferred revenue 9.45M
Commitments and contingencies
Common stock, $0.001 par value; 60,000 shares authorized; 35,438 and 35,227 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively 63K
Additional paid-in capital 691.42M
Accumulated other comprehensive income (loss) 106K
Accumulated deficit -683.69M
Total stockholders' equity 7.9M
Total liabilities and stockholders' equity 150.19M